Banikova Sarka, Najsrova Alice, Szegedi Istvan, Vitova Katerina, Fiedorova Iva, Trda Jana, Volny Ondrej
Department of Rehabilitation and Sports Medicine, University Hospital Ostrava, Ostrava, Czechia.
Centre for Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czechia.
Front Rehabil Sci. 2025 Aug 26;6:1660766. doi: 10.3389/fresc.2025.1660766. eCollection 2025.
Virtual reality (VR) rehabilitation represents a promising technological approach in post-stroke neurorehabilitation, offering immersive, engaging therapy environments. However, limited data exist on patient satisfaction and tolerance in clinical practice, particularly during the subacute phase of stroke recovery.
To evaluate patient satisfaction and tolerance of VR rehabilitation in patients with subacute ischemic stroke and assess physiotherapist perceptions of treatment outcomes compared to conventional rehabilitation.
A prospective pilot study was conducted from January 1, 2024, to December 31, 2024, at the Department of Neurology, University Hospital Ostrava, Czech Republic. Patients in the subacute phase of ischemic stroke (≤2 weeks post-stroke) underwent VR rehabilitation using the MDR-certified VR Vitalis® Pro system. Patient satisfaction was measured using the User Satisfaction Evaluation Questionnaire (USEQ) with individual question analysis. Physiotherapists assessed treatment outcomes on a 5-point scale compared to conventional rehabilitation. Vital signs were monitored pre- and post-intervention.
Nineteen patients (mean age 67.7 ± 11.2 years, 52.6% female) completed VR rehabilitation. The mean USEQ satisfaction score was 25.0 ± 6.8 points (range 7-30). High satisfaction (≥25 points) was achieved in 68.4% of patients, with only 5.3% reporting low satisfaction (<15 points). Individual question analysis revealed highest ratings for information clarity (4.63 ± 0.96) and perceived rehabilitation benefit (4.37 ± 1.12), with excellent tolerability as 63.2% reported no discomfort. Physiotherapists rated 31.6% of patients as showing better outcomes than expected with conventional therapy, while 52.6% showed similar outcomes and 15.8% showed worse outcomes. The mean number of VR sessions per patient was 4.2 ± 4.1. No serious adverse events were recorded.
VR rehabilitation demonstrated high patient satisfaction and excellent tolerance in subacute stroke patients. Individual USEQ analysis revealed particularly strong acceptance for system clarity and rehabilitation benefit. These findings support the feasibility and acceptability of VR rehabilitation in clinical stroke care.
虚拟现实（VR）康复是中风后神经康复中一种很有前景的技术方法，可提供沉浸式、引人入胜的治疗环境。然而，关于临床实践中患者满意度和耐受性的数据有限，尤其是在中风恢复的亚急性期。
评估亚急性缺血性中风患者对VR康复的满意度和耐受性，并评估物理治疗师对与传统康复相比的治疗结果的看法。
2024年1月1日至2024年12月31日，在捷克共和国俄斯特拉发大学医院神经内科进行了一项前瞻性试点研究。缺血性中风亚急性期（中风后≤2周）的患者使用经MDR认证的VR Vitalis® Pro系统进行VR康复。使用用户满意度评估问卷（USEQ）并进行个体问题分析来测量患者满意度。与传统康复相比，物理治疗师以5分制评估治疗结果。在干预前后监测生命体征。
19名患者（平均年龄67.7±11.2岁，52.6%为女性）完成了VR康复。USEQ平均满意度评分为25.0±6.8分（范围7 - 30）。68.4%的患者达到高满意度（≥25分），只有5.3%的患者报告低满意度（<15分）。个体问题分析显示，信息清晰度（4.63±0.96）和感知康复益处（4.37±1.12）的评分最高，63.2%的患者报告无不适，耐受性良好。物理治疗师将31.6%的患者评为比传统治疗预期效果更好，52.6%的患者效果相似，15.8%的患者效果更差。每位患者的VR治疗平均次数为4.2±4.1次。未记录到严重不良事件。
VR康复在亚急性中风患者中显示出高患者满意度和良好耐受性。USEQ个体分析显示对系统清晰度和康复益处的接受度特别高。这些发现支持了VR康复在临床中风护理中的可行性和可接受性。
